Quick search:
Content Search
Result Content Research
Result Content Research
1 DMC Global (BOOM) falls 1.11% to Close at $39.97 on September 16
2 DMC Global inc (BOOM) Q2 2021 Earnings Call Transcript
3 Add Up The Pieces: OIH Could Be Worth $226
4 DMC Global Announces Pricing of Public Offering of Common Stock
5 How to Buy DMC Global Inc. (BOOM) Stock • Benzinga
6 DMC Global Schedules Second Quarter Earnings Release and
7 Yvon Cariou Retires From DMC Global's Board of Directors
8 Is DMC Global (BOOM) A Good Stock To Buy Now?
9 DMC Global Announces Proposed Public Offering of Common Stock
10 DMC Global Down 10% After Quarterly Results and Guidance
11 A Preview Of DMC Global's Earnings
12 DMC Global Reports First Quarter Financial Results
13 Cybercriminal Attacks Accelerate Global Cybersecurity Crisis... | MENAFN.COM
14 DMC Global Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
15 DynaEnergetics Announces Global Price Increase
16 Biophytis Reports H1 2021 Financial Results and Provides Business Update
17 Ruth I. Dreessen Appointed to DMC Global's Board of Directors
18 BOOM Stock Forecast, Price & News (DMC Global)
19 50 Stocks Moving In Friday's Mid-Day Session
20 Why DMC Global Stock Soared 40% in April
21 DMC Global Announces Promotion of Antoine Nobili to President of NobelClad
22 Zscaler, Inc. (ZS) Q4 2021 Earnings Call Transcript
23 Mass. public companies show creativity in choice of ticker symbols
24 Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase
25 Today's Stock Market News & Events: 7/22/2021
26 AzurRx BioPharma To Acquire First Wave Bio In Transformative $229 Million Deal; Significantly Expands GI and IBD Treatment Pipeline (NASDAQ: AZRX)
27 Midday Hot Stocks: GM recall; SSB, BOOM fall on earnings; LPRO downgrade; ARVN working with PFE
28 NobelClad Launches DetaPipe™ Clad Pipe Solution
29 DMC Global Reports Fourth Quarter and Full-Year Financial Results
30 DMC Global Issues Letter to Stakeholders From President & Ceo Kevin Longe
31 DMC Global's Oilfield Products Business Completes Capacity
32 DMC Global Raises First Quarter Sales Forecast
33 EMERGING MARKETS-Asian FX, stocks slip as markets turn risk averse; won eases
34 Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue the Mino-Lok® Phase 3 Trial as Planned
35 Want to get in on hot energy stocks? Wall Street favors these 20 picks for gains up to 40%
36 DMC Global Reports Record Fourth Quarter Financial Results
37 DMC Global Declares Quarterly Cash Dividend
38 Dynamic Materials Corp. changes name to DMC Global – BizWest
39 Xometry files for proposed IPO on Nasdaq Global Select Market
40 DynaEnergetics' New DS Gravity™ and DS LoneStar™ Perforating Systems Enable Innovative Completion Applications in Unconventional Oil
41 Blaming Trump's new tariffs, DMC Global unit says it's raising prices
42 2 “Strong Buy” Penny Stocks That Could See Outsized Gains
43 46 Stocks Moving in Wednesday's Pre-Market Session
44 Top Ranked Growth Stocks to Buy for April 27th
45 Fast Radius to go public on NASDAQ before end of 2021
46 Why Adverum Biotechnologies Stock Is Imploding Today
47 Citius: Halt For Superiority On The Horizon
48 The Valuation on NovoCure Stock Is a Tough Pill to Swallow, Says Analyst
49 Novocure's stock rockets into record territory after upbeat DMC review of lung cancer treatment trial
50 Aerie Pharmaceuticals Inc (AERI): Are Hedge Funds Right About This Stock?
51 Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones
52 NJ drivers headed to New York: Get ready for a new headache
53 Pluristem Announces DMC Recommendation Following Interim
54 MRNA, NVAX, RIOT and MARA among premarket gainers
55 Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
56 Andrea Bertone Appointed to DMC Global's Board of Directors
57 Metal 3D printing firm Freemelt to list on Nasdaq
58 Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?
59 Flywire Corporation (FLYW) Q2 2021 Earnings Call Transcript
60 AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
61 Where Do Hedge Funds Stand On Perdoceo Education Corporation (PRDO)?
62 Apellis Provides Update on APL-9 for Severe COVID-19
63 Caterpillar (CAT) or Deere (DE): Which Is the Better Stock?
64 DynaEnergetics Celebrates Grand Opening of DynaStage™
65 Citius Pharmaceuticals Achieves Next Interim Analysis Milestone in its Mino-Lok® Phase 3 Trial
66 Cigna Updates Medical Policy to Cover Hologic's Acessa® Procedure, Expanding Access to Millions of Women Across the Country
67 These 2 Penny Stocks Could Quadruple (Or More), Says H.C. Wainwright
68 $1+ Billion Dimethyl Carbonate Markets
69 CTXR: A Blockbuster Pharma Still Under The Radar
70 electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
71 Explosive device manufacturer DynaEnergetics opens DFW facility
72 Celsion Corporation Issues Letter to Stockholders
73 5 Stocks With Low Debt-to-Equity Ratio Worth Betting On
74 UAE financial organisations under pressure to increase security
75 The Daily Hit: July 28, 2021
76 Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update
77 Is GAN A Good Stock To Buy Now?
78 Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
79 AzurRx BioPharma Announces First Two Patients Dosed in Phase 2b OPTION 2 Extension Study of MS1819 in Cystic Fibrosis Patients
80 Biophytis Secures the Manufacturing of Sarconeos (BIO101)
81 DynaEnergetics Surpasses One Million DynaStage™ System Sales
82 Indiana developer proposes 221-unit apartment in southwest Broomfield
83 Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript
84 Apellis Pharmaceuticals Reports First Quarter 2021 Financial Results
85 Is CLNE A Good Stock To Buy Now?
86 Citius Pharmaceuticals to Present Corporate Update at Benzinga Global Small Cap Conference on December 8
87 Is AAN Stock A Buy or Sell?
88 Citius Pharmaceuticals, Inc. Reports Second Fiscal Quarter 2021 Financial Results and Provides General Business Update
89 BeiGene Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell Lung Cancer Met the Primary Endpoint of Overall Survival at Interim Analysis
90 Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Updates
91 Intercept Pharmaceuticals Inc (ICPT) Q4 2020 Earnings Call Transcript
92 Adverum Reports First Quarter 2021 Results
93 Celsion Corporation Reports 2020 Financial Results and Provides Business Update
94 Zai Lab Announces First Quarter 2021 Financial Results
95 6 Stocks To Watch For March 23, 2020
96 Novocure Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
97 Biophytis Receives Favorable Recommendation From Data
98 Markforged set to go public on New York Stock Exchange
99 Fathom to go public on New York Stock Exchange through SPAC merger
100 Adverum Provides Update on ADVM-022 and the INFINITY Trial